Guided Therapeutics

(OTC) GTHP

Current Price$0.28

Market Cap$23.65M

Since IPO (1997)-100%

5 Year-63%

1 Year+7%

1 Month+20%

Guided Therapeutics Financials at a Glance

Market Cap

$23.65M

Revenue (TTM)

$767.00K

Net Income (TTM)

-$3.93M

EPS (TTM)

-$0.05

P/E Ratio

-5.29

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$0.28

Volume

5,570

Open

$0.28

Price

$0.28

Volume

5,570

Open

$0.28

Previous Close

$0.28

Daily Range

$0.24 - $0.28

52-Week Range

$0.12 - $0.54

Estimated Earnings Date

May 13, 2026

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$0.28

Volume

5,570

Open

$0.28

Previous Close

$0.28

Daily Range

$0.24 - $0.28

52-Week Range

$0.12 - $0.54

Estimated Earnings Date

May 13, 2026

GTHP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guided Therapeutics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Mark L. Faupel, PhD

Website

www.guidedinc.com

Headquarters

Norcross, GA 30092, US

GTHP Financials

Key Financial Metrics (TTM)

Gross Margin

67.93%

Operating Margin

-322.95%

Net Income Margin

-512.65%

Return on Equity

70.53%

Return on Capital

N/A

Return on Assets

-245.14%

Earnings Yield

-18.90%

Dividend Yield

0.00%

Payout Ratio

-2.06%

Stock Overview

Market Cap

$23.65M

Shares Outstanding

96.54M

Volume

5.57K

Avg. Volume

14.09K

Financials (TTM)

Gross Profit

$521.00K

Operating Income

-$2.48M

EBITDA

-$2.71M

Operating Cash Flow

-$1.35M

Capital Expenditure

-$2.00K

Free Cash Flow

-$1.36M

Cash & ST Invst.

$369.00K

Total Debt

$2.79M

Guided Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.00K

+4.0%

Gross Margin

0.00%

N/A

Market Cap

$23.65M

N/A

Market Cap/Employee

$5.91M

N/A

Employees

N/A

Net Income

-$1.01M

-137.2%

EBITDA

-$495.00K

-94.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$369.00K

+220.9%

Total Debt

$2.79M

+38.5%

Accounts Receivable

$4.00K

+100.0%

Inventory

$469.00K

-25.9%

Long Term Debt

$818.00K

+605.2%

Short Term Debt

$1.97M

+2.7%

Return on Assets

-2.45%

N/A

Return on Invested Capital

56.84%

N/A

Free Cash Flow

-$617.00K

-86.4%

Operating Cash Flow

-$617.00K

-86.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EMITFElbit Imaging Ltd.

EMITFElbit Imaging Ltd.$1.60+0.00%

PYNKFPerimeter Medical Imaging AI, Inc.

PYNKFPerimeter Medical Imaging AI, Inc.$0.19+0.00%

ZHCLFZenith Capital Corp.

ZHCLFZenith Capital Corp.$0.10+0.00%

UEECUnited Health Products, Inc.

UEECUnited Health Products, Inc.$0.06+6.77%

VPTDFVentriPoint Diagnostics Ltd.

VPTDFVentriPoint Diagnostics Ltd.$0.08-4.66%

ASAPFAurora Spine Corporation

ASAPFAurora Spine Corporation$0.17-4.29%

CRVWCareView Communications, Inc.

CRVWCareView Communications, Inc.$0.06+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About GTHP

What is the current price of Guided Therapeutics?

Guided Therapeutics is trading at $0.28 per share.

What is the 52-week range for Guided Therapeutics?

Over the past 52 weeks, Guided Therapeutics has traded between $0.12 and $0.54.

How much debt does Guided Therapeutics have?

As of the most recent reporting period, Guided Therapeutics reported total debt of $2.79M.

How much cash does Guided Therapeutics have on hand?

Guided Therapeutics reported $369.00K in cash and cash equivalents in its most recent financial results.

What is Guided Therapeutics’s dividend yield?

Guided Therapeutics does not currently have a dividend yield.

Guided Therapeutics

Guided Therapeutics Financials at a Glance

GTHP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Guided Therapeutics

GTHP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Guided Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GTHP

What is the current price of Guided Therapeutics?

What is the 52-week range for Guided Therapeutics?

How much debt does Guided Therapeutics have?

How much cash does Guided Therapeutics have on hand?

What is Guided Therapeutics’s dividend yield?

Premium Investing Services